Literature DB >> 16688112

Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin.

So-Hyang Chung1, Su Kyung Lee, Stephen M Cristol, Eun Suk Lee, Dong Wook Lee, Kyoung Yul Seo, Eung Kweon Kim.   

Abstract

PURPOSE: The aim of this study is to investigate the short-term effects of benzalkonium chloride (BAC), a preservative used in many ophthalmic topical solutions, on precorneal mucin in humans.
METHODS: Immortalized human corneal-limbal epithelial (HCLE) cells were exposed to eyedrops containing BAC solutions at 0.0025% and 0.01% concentrations for a period of 15 min. Human corneal epithelium was acquired with consent, as a byproduct of elective excimer photorefractive keratectomy procedures after application of Ocuflox eyedrops (0.3% ofloxacin with 0.0025% BAC) for 1 week before surgery. The relative expression of the MUC1 and MUC16 mucin gene was determined by conventional and real-time reverse transcription-polymerase chain reaction (RT-PCR). Monoclonal antibodies for MUC1 (HMFG-1) and MUC16 (OC125) were used in western blot analysis to detect MUC1 and MUC16. Human corneas exposed to 0.01% BAC solutions were examined by transmission electron microscopy.
RESULTS: The expression of MUC1 and MUC16 gene transcripts was not changed after exposure to BAC in HCLE cells and human corneal epithelium. However, MUC1 and MUC16 were reduced after exposure to BAC in HCLE cells and human corneal epithelium. Transmission electron microscopy of the anterior corneal surface revealed fixation of the mucous layer after exposure to 0.01% BAC for 5 or 15 min; prolonged exposure (60 min) to 0.01% BAC destroys the mucous layer.
CONCLUSIONS: This study demonstrates that short-term exposure to BAC can alter the precorneal mucin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16688112

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  15 in total

1.  Cytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitro.

Authors:  Mary M Feng; Julia Baryla; Hong Liu; Gordon W Laurie; Robert L McKown; Negin Ashki; Dinesh Bhayana; Cindy M L Hutnik
Journal:  Curr Eye Res       Date:  2014-01-08       Impact factor: 2.424

2.  [A comparative in vitro analysis of primary and immortalized keratocytes].

Authors:  L Kagan; P W Rieck
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

3.  Preparation of benzalkonium salts differing in the length of a side alkyl chain.

Authors:  Kamil Kuca; Jan Marek; Petr Stodulka; Kamil Musilek; Petra Hanusova; Martina Hrabinova; Daniel Jun
Journal:  Molecules       Date:  2007-10-24       Impact factor: 4.411

4.  In vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells.

Authors:  Ana Guzman-Aranguez; Patricia Calvo; Inés Ropero; Jesús Pintor
Journal:  J Ocul Pharmacol Ther       Date:  2014-08-06       Impact factor: 2.671

5.  Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits.

Authors:  H Liang; F Brignole-Baudouin; L Rabinovich-Guilatt; Z Mao; L Riancho; M O Faure; J M Warnet; G Lambert; C Baudouin
Journal:  Mol Vis       Date:  2008-01-31       Impact factor: 2.367

6.  Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study.

Authors:  Wenqing Zhu; Xiangmei Kong; Jianjiang Xu; Xinghuai Sun
Journal:  J Ophthalmol       Date:  2015-06-15       Impact factor: 1.909

7.  Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study.

Authors:  Pinnita Prabhasawat; Ngamkae Ruangvaravate; Nattaporn Tesavibul; Maneerat Thewthong
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-19       Impact factor: 2.671

8.  Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.

Authors:  Tejaswini Walimbe; Vidya Chelerkar; Purvi Bhagat; Abhijeet Joshi; Atul Raut
Journal:  Clin Ophthalmol       Date:  2016-05-09

9.  IGF-1 counteracts TGF-beta-mediated enhancement of fibronectin for in vitro human lens epithelial cells.

Authors:  So-Hyang Chung; Sun-Ah Jung; Young Jae Cho; Joon H Lee; Eung Kweon Kim
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 10.  Ocular surface mucins and local inflammation--studies in genetically modified mouse lines.

Authors:  Kumi Shirai; Shizuya Saika
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.